Applied Molecular Transport Inc. announced the appointment of Carolyn Finkle as senior vice president, head of regulatory affairs. She becomes a member of the AMT executive leadership team, reporting to chief executive officer and co-founder of AMT, Tahir Mahmood, Ph.D. Ms. Finkle joins with more than thirty years of experience leading regulatory strategy, product development and product approvals for global biotechnology organizations. Most recently, Ms. Finkle served as chief operating officer and head of regulatory affairs at Medicago.

Prior to her role at Medicago, she was the vice president of regulatory affairs at Karyopharm, head of U.S. commercialization and global client partnerships at Kinapse, and senior vice president of regulatory and pharmacovigilance at inVentiv Health. Ms. Finkle also previously held leadership roles in regulatory affairs and product development for Catalent, MedImmune, PAREXEL and Celsion. She currently serves as an adjunct lecturer at Georgetown University Graduate School and course co-director for the Pharmaceutical Education and Research Institute (PERI).